# Partially HLA Mismatched (Haploidentical) Allogeneic Bone Marrow Transplantation

> **NCT01749293** · PHASE2 · TERMINATED · sponsor: **University of Illinois at Chicago** · enrollment: 3 (actual)

## Conditions studied

- Hematologic Malignancies

## Interventions

- **PROCEDURE:** Haploidentical Transplant
- **DRUG:** Fludarabine
- **DRUG:** Busulfan
- **RADIATION:** Total Body Irradiation
- **DRUG:** Cyclophosphamide

## Key facts

- **NCT ID:** NCT01749293
- **Lead sponsor:** University of Illinois at Chicago
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-08-30
- **Primary completion:** 2014-05-15
- **Final completion:** 2014-05-15
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** The protocol design is being reconfigured in order to open a new study.
- **Last updated:** 2020-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01749293

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01749293, "Partially HLA Mismatched (Haploidentical) Allogeneic Bone Marrow Transplantation". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01749293. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*